🔎 Trials Near Me

Utama › Glioma › Ohio › Columbus

Kajian klinikal Glioma di Columbus, OH

15 kajian untuk Glioma sedang mencari peserta di lokasi dalam dan sekitar Columbus (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Mengambil pesertaFasa 1/2
  • Nationwide Children's Hospital, Columbus
12 Months – 21 Years · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Mengambil pesertaFasa 2
  • Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Mengambil pesertaFasa 2
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Mengambil pesertaKajian pemerhatian
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Mengambil pesertaFasa 2
  • Nationwide Children's Hospital, Columbus
Umur 12 hingga 39 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Mengambil pesertaFasa 2
  • Nationwide Children's Hospital, Columbus
Umur 3 hingga 39 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Mengambil pesertaFasa 2
  • The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

Mengambil peserta
  • Ohio State University Medical Center, Columbus
Umur 18 hingga 85 · Semua jantina · Dikemas kini 21 Jul 2026 · NCT06910306

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Mengambil pesertaFasa 1/2
  • Nationwide Children's Hospital, Columbus
Umur 4 hingga 39 · Semua jantina · Dikemas kini 20 Jul 2026 · NCT05278208

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
  • Nationwide Children's Hospital, Columbus
Umur 1 hingga 21 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Mengambil pesertaFasa 2
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Semua jantina · Dikemas kini 29 Mei 2026 · NCT05843253

Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas

Mengambil pesertaFasa 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Mei 2026 · NCT06964737

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Mengambil pesertaFasa 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Apr 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Mengambil pesertaFasa awal 1
  • Nationwide Children's Hospital, Columbus
Sehingga umur 21 · Semua jantina · Dikemas kini 18 Mac 2026 · NCT04655404

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

Mengambil pesertaFasa 1
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Semua jantina · Dikemas kini 13 Mei 2025 · NCT04254419

Kajian Glioma di bandar lain

Kajian lain di Columbus

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.